Unfortunately money enters the equation. The smaller the target population - the number of people at risk for a particular disease - the fewer the recipients. Costs of development are very high. Indeed, before the mid-1980s, vaccines were very cheap, and it was said that vaccines are to drug companies as hub caps are to General Motors, i.e., a very subsidiary product.
0 comments:
Post a Comment